Ifeanyichukwu Chinedu Ogobuiro

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Nipun B. Merchant · 6 shared papers, 2023–2025 · strength 1.06
   • Paper ASO Author Reflections: Racial Disparities in Chemoresponsivity in Localized Pancreatic Cancer: Nature or Nurture? DOI 10.1245/s10434-022-12843-z↗
   • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
2. Jashodeep Datta · 4 shared papers, 2023 · strength 0.68
   • Paper ASO Author Reflections: Racial Disparities in Chemoresponsivity in Localized Pancreatic Cancer: Nature or Nurture? DOI 10.1245/s10434-022-12843-z↗
   • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
   • Paper Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. DOI 10.1200/po.23.00152↗
3. Haleh Amirian · 3 shared papers, 2023–2025 · strength 0.50
   • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
   • Paper Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreati… DOI 10.1158/2159-8290.cd-22-1046↗
4. Iago De Castro Silva · 3 shared papers, 2023–2025 · strength 0.49
   • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
   • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
   • Paper Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreati… DOI 10.1158/2159-8290.cd-22-1046↗
5. Gregory C. Wilson · 3 shared papers, 2023–2024 · strength 0.45
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
   • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
   • Paper Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. DOI 10.1200/po.23.00152↗
6. David A. Kooby · 3 shared papers, 2023–2024 · strength 0.45
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
   • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
   • Paper Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. DOI 10.1200/po.23.00152↗
7. Daniel Erik Abbott · 3 shared papers, 2023–2024 · strength 0.45
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
   • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
   • Paper Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. DOI 10.1200/po.23.00152↗
8. Shishir Kumar Maithel · 3 shared papers, 2023–2024 · strength 0.45
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
   • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
   • Paper Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. DOI 10.1200/po.23.00152↗
9. Caitlin A. Hester · 2 shared papers, 2023–2024 · strength 0.43
   • Paper ASO Author Reflections: Racial Disparities in Chemoresponsivity in Localized Pancreatic Cancer: Nature or Nurture? DOI 10.1245/s10434-022-12843-z↗
   • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
10. Jashodeep Datta · 2 shared papers, 2024–2025 · strength 0.38
    • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
11. Christine Isabelle Rafie · 2 shared papers, 2023–2025 · strength 0.34
    • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
    • Paper Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreati… DOI 10.1158/2159-8290.cd-22-1046↗
12. Nilesh Deshpande · 2 shared papers, 2023–2025 · strength 0.34
    • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
    • Paper Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreati… DOI 10.1158/2159-8290.cd-22-1046↗
13. Siddharth Mehra · 2 shared papers, 2023–2025 · strength 0.34
    • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
    • Paper Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreati… DOI 10.1158/2159-8290.cd-22-1046↗
14. Nagaraj S. Nagathihalli · 2 shared papers, 2023–2025 · strength 0.34
    • Paper Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invig… DOI 10.1007/s00262-025-04096-y↗
    • Paper Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreati… DOI 10.1158/2159-8290.cd-22-1046↗
15. Alexander A. Parikh · 2 shared papers, 2023–2024 · strength 0.31
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
    • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
16. Hong Joo Kim · 2 shared papers, 2023–2024 · strength 0.31
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
    • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
17. Rebecca Anne Snyder · 2 shared papers, 2023–2024 · strength 0.31
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
    • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
18. Chet W. Hammill · 2 shared papers, 2023–2024 · strength 0.31
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
    • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
19. Syed Arif Ahmad · 2 shared papers, 2023–2024 · strength 0.30
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
    • Paper Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. DOI 10.1200/po.23.00152↗
20. Erin M. Dickey · 1 shared paper, 2024 · strength 0.16
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
21. Mary P Martos · 1 shared paper, 2024 · strength 0.16
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
22. Syed Nabeel Zafar · 1 shared paper, 2024 · strength 0.16
    • Paper Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected panc… DOI 10.1002/jso.27798↗
23. Patrick Beard Schwartz · 1 shared paper, 2023 · strength 0.15
    • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
24. Syed Ameen Ahmad · 1 shared paper, 2023 · strength 0.15
    • Paper Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Insti… DOI 10.1245/s10434-022-12741-4↗
25. Rachna T. Shroff · 1 shared paper, 2023 · strength 0.14
    • Paper Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer. DOI 10.1200/po.23.00152↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.